Sectors
PMCB
PharmaCyte Biotech, Inc.
0.55
1 x 0.55
1 x 0.65
bid
ask
+
0.00
0.73%
09:30 AM
timesize
| Ytd | -24.03% | |
| 1y | -33.73% |
0.55
day range
0.55
0.55
52 week range
1.51
| Open | 0.55 | Prev Close | 0.55 | Low | 0.55 | High | 0.55 | Mkt Cap | 3.74M |
| Vol | 142.00 | Avg Vol | 185.96K | EPS | 1.45 | P/E | 0.38 | Forward P/E | -4.21 |
| Beta | 0.57 | Short Ratio | 1.09 | Inst. Own | 13.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.69 | 200-d Avg | 0.77 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 2.51M | ||
| Research and Development Expense | 61.95K | ||
| Selling, General and Administrative Expense | 899.88K | ||
| Operating Income | -2.51M | ||
| Net Income | -4.39M | ||
| Net Income Common Stock | -4.87M | ||
| Net Income Common Stock (USD) | -4.87M | ||
| Consolidated Income | -4.39M | ||
| Earnings per Basic Share | -0.36 | ||
| Earnings per Basic Share (USD) | -0.36 | ||
| Earnings per Diluted Share | -0.36 | ||
| Earning Before Interest & Taxes (EBIT) | -4.39M | ||
| Earning Before Interest & Taxes (USD) | -4.39M | ||
| Preferred Dividends Income Statement Impact | 479.97K | ||
| Weighted Average Shares | 8.38M | ||
| Weighted Average Shares Diluted | 8.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.60M | ||
| Cash and Equivalents (USD) | 18.60M | ||
| Investments | 27.80M | ||
| Investments Current | 18.48M | ||
| Investments Non-Current | 9.32M | ||
| Trade and Non-Trade Receivables | 240.77K | ||
| Current Assets | 37.42M | ||
| Total Assets | 46.75M | ||
| Current Liabilities | 826.42K | ||
| Total Liabilities | 11.77M | ||
| Accumulated Retained Earnings (Deficit) | -104.39M | ||
| Accumulated Other Comprehensive Income | -20.80K | ||
| Shareholders Equity | 33.29M | ||
| Shareholders Equity (USD) | 33.29M | ||
| Assets Non-Current | 9.33M | ||
| Liabilities Non-Current | 10.95M | ||
| Trade and Non-Trade Payables | 271.10K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -169.82K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.56M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -3.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 3.00M | ||
| Net Cash Flow from Operations | -1.39M | ||
| Effect of Exchange Rate Changes on Cash | 744.00 | ||
| Share Based Compensation | 54.58K | ||